• KinATLAS
  • TranscriptoNET
  • PhosphoNET
  • OncoNET
  • KinaseNET
  • DrugKiNET
  • DrugProNET
  • KiNET-AM
  • Kinetica Online

Updated November 2019

Home | Kinexus | Contact | Credits

Nomenclature

Short Name:
BRSK1
Full Name:
BR serine/threonine-protein kinase 1
Alias:
  • BR serine/threonine kinase 1
  • EC 2.7.11.1
  • KIAA1811
  • SAD1
  • SAD1 kinase
  • SAD1A

Classification

Type:
Protein-serine/threonine kinase
Group:
CAMK
Family:
CAMKL
SubFamily:
BRSK
 
 

Specific Links

Entrez-Protein Entry: NP_115806
GeneCards Entry: KIAA1811
KinBASE Entry: BRSK1
OMIM Entry: 609235
Pfam Entry: Q8TDC3
PhosphoNET Entry: Q8TDC3
Phosphosite Plus Entry: 2097
ScanSite Entry: Q8TDC3
Source Entry: BRSK1
UniProt Entry: Q8TDC3
Kinexus Products: BRSK1
BR serine/threonine-protein kinase 1 T189 phosphosite-specific antibody AB-PK549
BrskSelectide - BRSK1 protein kinase substrate peptide - Powder PE-01BGK99
BR serine/threonine-protein kinase 1 (L186-G192, human) pT189 phosphopeptide - Powder PE-04AIW95

General Links

ClustalW2
GPS-Cuckoo
Human Protein Atlas
Kinase.com
Kinase Research
Kinasource
Kinomer
Netphorest
NetworKIN
Phosida
PhosphoElm
Protein Blast
ScanSite
String

Structure

Mol. Mass (Da):
86,753
# Amino Acids:
794
# mRNA Isoforms:
3
mRNA Isoforms:
86,753 Da (794 AA; Q8TDC3-2); 85,087 Da (778 AA; Q8TDC3); 38,782 Da (343 AA; Q8TDC3-3)
4D Structure:
NA
1D Structure:
Retrieve Gene Sequence
Retrieve Full Protein Sequence
Retrieve Catalytic Domain Sequence
 
Subfamily Alignment
subfamily domain
 
Domain Distribution:
Start End Domain
34 285 Pkinase
330 372 UBA
 

Kinexus Products

Click on entries below for direct links to relevant products from Kinexus for this protein kinase.
hiddentext
○ BR serine/threonine-protein kinase 1 T189 phosphosite-specific antibody AB-PK549
○ BrskSelectide - BRSK1 protein kinase substrate peptide - Powder PE-01BGK99
○ BR serine/threonine-protein kinase 1 (L186-G192, human) pT189 phosphopeptide - Powder PE-04AIW95
 

Post-translation Modifications

For detailed information on phosphorylation of this kinase go to PhosphoNET
Serine phosphorylated:

S193-, S275, S399, S404, S413, S427, S432, S443, S447, S508, S515, S563, S587.
Threonine phosphorylated:

T189+, T417, T583, T772.
 

Distribution

Based on gene microarray analysis from the NCBI
Human Tissue Distribution
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
  • adipose
    100

    1782

    9

    1707

  • adrenal
    19

    338

    6

    513

  • bladder
    -

    -

    -

    -

  • brain
    77

    1381

    30

    2893

  • breast
    37

    658

    10

    450

  • cervix
    0.8

    14

    9

    10

  • colon
    5

    96

    13

    56

  • heart
    45

    809

    7

    893

  • intestine
    2

    30

    3

    5

  • kidney
    47

    837

    7

    891

  • liver
    27

    474

    7

    716

  • lung
    46

    819

    13

    594

  • lymphnode
    25

    437

    2

    356

  • ovary
    18

    317

    5

    490

  • pancreas
    34

    598

    7

    728

  • pituitary
    8

    138

    7

    175

  • prostate
    17

    304

    11

    532

  • salivarygland
    24

    427

    5

    552

  • skeletalmuscle"
    55

    982

    5

    1328

  • skin
    27

    478

    28

    217

  • spinalcord
    83

    1483

    7

    2236

  • spleen
    19

    345

    5

    391

  • stomach
    -

    -

    -

    -

  • testis
    43

    772

    7

    985

  • thymus
    27

    488

    7

    458

  • thyroid
    36

    636

    21

    610

  • tonsil
    5

    81

    5

    50

  • trachea
    22

    389

    5

    512

  • uterus
    6

    114

    5

    169

  • reticulocytes"
    -

    -

    -

    -

  • t-lymphocytes
    59

    1043

    12

    59

  • b-lymphocytes
    38

    680

    13

    2173

  • neutrophils
    0.2

    4

    12

    0

  • macrophages
    45

    793

    26

    415

  • sperm
    14

    244

    22

    153

 

Evolution

Species Conservation
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
  • tableheader
    100

    100

    100
  • tableheader
    0

    0

    99
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    99
  • tableheader
    -

    -

    -
  • tableheader
    98.1

    98.2

    98
  • tableheader
    -

    -

    -
  • tableheader
    94.8

    95.4

    99
  • tableheader
    29.2

    44.5

    99
  • tableheader
    -

    -

    -
  • tableheader
    32.1

    33.3

    -
  • tableheader
    28.3

    43.9

    -
  • tableheader
    -

    -

    84
  • tableheader
    25.1

    38.5

    81
  • tableheader
    -

    -

    -
  • tableheader
    48.5

    62.5

    53
  • tableheader
    -

    -

    -
  • tableheader
    25.7

    37.9

    34
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    27

    41.9

    -
  • tableheader
    22.2

    34.2

    -
  • tableheader
    -

    -

    -
For a wider analysis go to PhosphoNET Evolution in PhosphoNET
 

Binding Proteins

Examples of known interacting proteins
hiddentext
No. Name – UniProt ID
1 CDC25C - P30307
2 CDC25B - P30305
3 WEE1 - P30291
4 NUAK1 - O60285
 

Regulation

Activation:
Activated by phosphorylation on Thr-205 by STK11 in complex with STE20-related adapter-alpha (STRAD alpha) pseudo kinase and CAB39
Inhibition:
NA
Synthesis:
NA
Degradation:
NA
 

Known Upstream Kinases

For further details on these substrates click on the Substrate Short Name or UniProt ID. Phosphosite Location is hyperlinked to PhosphoNET predictions.
Based on in vitro and/or in vivo phosphorylation data

Kinase Short Name UniProt ID (Human) Phosphosite Location Phosphosite Sequence Effect of Phosphorylation
CaMK2a Q9UQM7 T189 VGDSLLETSCGSPHY +
BRSK1 Q8TDC3 T189 VGDSLLETSCGSPHY +
LKB1 Q15831 T189 VGDSLLETSCGSPHY +
BRSK1 Q8TDC3 S193 LLETSCGSPHYACPE -
 

Known Downstream Substrates

For further details on these substrates click on the Substrate Short Name or UniProt ID. Phosphosite Location is hyperlinked to PhosphoNET predictions.
Based on in vitro and/or in vivo phosphorylation data

Substrate Short Name UniProt ID (Human) Phosphosite Location Phosphosite Sequence Effect of Phosphorylation
AMPKa1 (PRKAA1) Q13131 T183 SDGEFLRTSCGSPNY +
BRSK1 Q8TDC3 S193 LLETSCGSPHYACPE -
BRSK1 Q8TDC3 T189 VGDSLLETSCGSPHY +
Cdc25B P30305 S375 ARVLRSKSLCHDEIE
Cdc25C P30307 S216 SGLYRSPSMPENLNR ?
MAPT/TAU P10636 S579 NVKSKIGSTENLKHQ
MAPT/TAU P10636 T529 TPGSRSRTPSLPTPP
TUBG1 P23258 S131 READGSDSLEGFVLC +
TUBG2 Q9NRH3 S131 READGSDSLEGFVLC +
Wee1 P30291 S642 KKMNRSVSLTIY___ -
 

Protein Kinase Specificity

Matrix of observed frequency (%) of amino acids in aligned protein substrate phosphosites

Kinections GIF
Matrix Type:
Predicted from the application of the Kinexus Kinase Substrate Predictor Version 2.0 algorithm, which was trained with over 10,000 kinase-protein substrate pairs and 8,000 kinase-peptide substrate pairs.
Domain #:
1
 

Inhibitors

For further details on these inhibitors click on the Compound Name and enter it into DrugKiNET or click on the ID's
Based on in vitro and/or in vivo phosphorylation data
Compound Name KD, Ki or IC50 (nM) PubChem ID ChEMBL ID PubMed ID
PP242 Kd = 14 nM 25243800 22037378
Cdk1/2 Inhibitor III IC50 < 25 nM 5330812 261720 22037377
K-252a; Nocardiopsis sp. IC50 < 25 nM 3813 281948 22037377
Lestaurtinib Kd = 25 nM 126565 22037378
Staurosporine Kd = 26 nM 5279 18183025
GSK-3 Inhibitor IX IC50 < 40 nM 5287844 409450
TTT-3002 IC50 < 40 nM
PKR Inhibitor IC50 > 50 nM 6490494 235641 22037377
AT9283 IC50 > 100 nM 24905142 19143567
AG-E-60384 IC50 > 150 nM 6419741 413188 22037377
ALX-270-403-M001 IC50 > 150 nM 22037377
BCP9000906 IC50 > 150 nM 5494425 21156 22037377
Gö6976 IC50 > 150 nM 3501 302449 22037377
Indirubin-3′-monoxime IC50 > 150 nM 5326739 22037377
JAK3 Inhibitor VI IC50 > 150 nM 16760524 22037377
N-Benzoylstaurosporine IC50 > 150 nM 56603681 608533 22037377
SB218078 IC50 > 150 nM 447446 289422 22037377
Alsterpaullone IC50 > 250 nM 5005498 50894 22037377
GSK-3 Inhibitor X IC50 > 250 nM 6538818 430226 22037377
IDR E804 IC50 > 250 nM 6419764 1802727 22037377
SU11652 IC50 > 250 nM 24906267 13485 22037377
SU6656 IC50 > 250 nM 5353978 605003 22037377
NVP-TAE684 Kd = 310 nM 16038120 509032 22037378
Amgen TBK 1 inhibitor (Compound II) IC50 < 400 nM
GW 843682X IC50 < 400 nM 9826308 514499
Staurosporine aglycone IC50 < 400 nM 3035817 281948
Alsterpaullone; 2-Cyanoethyl IC50 = 500 nM 16760286 260138 22037377
Flt-3 Inhibitor II IC50 = 500 nM 11601743 377193 22037377
SU9516 IC50 = 500 nM 5289419 258805 22037377
Sunitinib IC50 = 500 nM 5329102 535 22037377
Syk Inhibitor IC50 = 500 nM 6419747 104279 22037377
IPA-3 IC50 < 600 nM 521106 472940
Syk Inhibitor IV IC50 < 600 nM 10200390
Momelotinib IC50 < 750 nM 25062766 19295546
BX795 IC50 < 800 nM 10077147 577784
GSK461364A IC50 < 800 nM 15983966 1908394
IKK-3 inhibitor IX IC50 < 800 nM 11626927 373751
Ro-31-8220 IC50 < 800 nM 5083 6291
GSK650394A IC50 > 900 nM 25022668 558642
1;9-Pyrazoloanthrone IC50 > 1 µM 8515 7064 22037377
Aurora A Inhibitor 23 (DF) Kd = 1 µM 21992004
Dovitinib IC50 > 1 µM 57336746 22037377
GSK2334470 IC50 = 1 µM 46215815 1765740
HG-10-102-01 IC50 = 1 µM
K00596a IC50 = 1 µM 9549298 200027
Kenpaullone IC50 > 1 µM 3820 296586 22037377
MK5108 IC50 > 1 µM 24748204 20053775
MNK1 Inhibitor IC50 > 1 µM 11644425 1240885 22037377
PF-3644022 IC50 = 1 µM
Purvalanol B IC50 = 1 µM 448991 23254
Silmitasertib IC50 > 1 µM 24748573 21174434
SNS314 IC50 > 1 µM 16047143 514582 18678489
WZ3146 Kd > 1 µM 44607360 20033049
WZ4002 Kd > 1 µM 44607530 20033049
KW2449 Kd = 1.9 µM 11427553 1908397 22037378
Quercetagetin IC50 < 2 µM 5281680 413552
GW441756 hydrochloride IC50 > 3 µM 16219400
Wyeth PDK1 Inhibitor Compound 1 IC50 > 3 µM
JNJ-28871063 IC50 > 4 µM 17747413 17975007
Purvalanol A IC50 > 4.5 µM 456214 23327
Syk Inhibitor II IC50 > 4.5 µM 16760670
Tofacitinib IC50 > 4.5 µM 9926791 221959
 

Disease Linkage

General Disease Association:

Menopause
Specific Diseases (Non-cancerous):

Premature ovarian failure (POF); age at natural menopause (AANM)
Comments:
The rs12611091 SNP in BRSK1 can lead to premature ovarian failure, which is a rare condition.
 
Mutagenesis Experiments:

Insertional mutagenesis studies in mice have not yet revealed a role for this protein kinase in mouse cancer oncogenesis. BRSK1's phosphotransferase activity was lost with the K59A, and G327A mutations.
Mutation Rate in All Cancers:

Percent mutation rates per 100 amino acids length in human cancers: 0.1 % in 24433 diverse cancer specimens. This rate is only 35 % higher than the average rate of 0.075 % calculated for human protein kinases in general.
Mutation Rate in Specific Cancers:

Highest percent mutation rates per 100 amino acids length in human cancers: 0.33 % in 1229 large intestine cancers tested; 0.21 % in 710 oesophagus cancers tested; 0.18 % in 555 stomach cancers tested; 0.16 % in 864 skin cancers tested; 0.14 % in 548 urinary tract cancers tested.
Frequency of Mutated Sites:

Most frequent mutations with the number of reports indicated in brackets: R303W (5).
Comments:
Twelve R379fs*9 deletions, 9 other deletions, 9 R379fs*54 insertions mutations, and no complex mutations.
 
COSMIC Entry:
BRSK1_ENST00000309383
OMIM Entry:
609235
  • Home
  • Top of Page
Copyright 2019 Kinexus BioInformatics Corporation